Inhibition of protein kinases by anticancer DNA intercalator, 4-butylaminopyrimido[4′,5′:4,5]thieno(2,3-b)quinoline
Open Access
- 1 May 2017
- journal article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 7 (3) , 303-310
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology (DBT) (BT/PR10513/BRB/10/618/2008)
- Ministry of Science and Technology
- Government of India (New Delhi)
This publication has 36 references indexed in Scilit:
- Novel Levamisole Derivative Induces Extrinsic Pathway of Apoptosis in Cancer Cells and Inhibits Tumor Progression in MicePLOS ONE, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- A novel DNA intercalator, butylamino-pyrimido[4′,5′:4,5]selenolo(2,3-b)quinoline, induces cell cycle arrest and apoptosis in leukemic cellsInvestigational New Drugs, 2009
- Combined xanthorrhizol-curcumin exhibits synergistic growth inhibitory activity via apoptosis induction in human breast cancer cells MDA-MB-231Cancer Cell International, 2009
- Intercalating, cytotoxic, antitumour activity of 8-chloro and 4-morpholinopyrimido [4′,5′:4,5]thieno(2,3-b)quinolinesJournal of Photochemistry and Photobiology B: Biology, 2009
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopyNature Protocols, 2007
- Mitochondrial Membrane Permeabilization in Cell DeathPhysiological Reviews, 2007
- Assay of protein kinases using radiolabeled ATP: a protocolNature Protocols, 2006
- The Hallmarks of CancerCell, 2000